ARCH THERAPEUTICS, INC.: 10-Q filed 2018-04-26
What ARCH THERAPEUTICS, INC. reported in its quarterly report filed 2018-04-26 (fiscal Q2 2018): 26 published measures, 71 facts as tagged in accession 0001144204-18-022685.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-04-26
- Fiscal period
- fiscal Q2 2018
- Accession
- 0001144204-18-022685 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARCH THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 3,466,583 | USD | |
| At 2017-09-30 | 6,090,083 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 1,391,977 | USD | |
| At 2017-09-30 | 3,863,564 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 2,074,606 | USD | |
| At 2017-09-30 | 2,226,519 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 3,377,998 | USD | |
| At 2017-09-30 | 5,994,052 | USD | |
| At 2017-03-31 | 7,230,310 | USD | |
| At 2016-09-30 | 5,036,476 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | -1,555,361 | USD | 90 |
| 2017-10-01 to 2018-03-31 | -1,166,185 | USD | 182 |
| 2017-09-29 to 2017-10-02 | -1,166,185 | USD | 4 |
| 2017-01-01 to 2017-03-31 | -1,869,432 | USD | 90 |
| 2016-10-01 to 2017-03-31 | -3,270,932 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | -2,669,548 | USD | 182 |
| 2016-10-01 to 2017-03-31 | -3,408,218 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | 9,894 | USD | 182 |
| 2016-10-01 to 2017-03-31 | 4,293 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | 0 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 0 | USD | 182 |
| 2017-01-01 to 2017-03-31 | 0 | USD | 90 |
| 2016-10-01 to 2017-03-31 | 0 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | 63,388 | USD | 182 |
| 2016-10-01 to 2017-03-31 | 5,606,345 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | -9,894 | USD | 182 |
| 2016-10-01 to 2017-03-31 | -4,293 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | -30,669,631 | USD | |
| At 2017-09-30 | -29,503,446 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 15,228 | USD | |
| At 2017-09-30 | 7,188 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | 950,884 | USD | 182 |
| 2016-10-01 to 2017-03-31 | 1,013,367 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | -2,013,845 | USD | 90 |
| 2017-10-01 to 2018-03-31 | -3,596,218 | USD | 182 |
| 2017-01-01 to 2017-03-31 | -2,204,123 | USD | 90 |
| 2016-10-01 to 2017-03-31 | -3,580,053 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 3,447,855 | USD | |
| At 2017-09-30 | 6,079,395 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | 0 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 0 | USD | 182 |
| 2017-01-01 to 2017-03-31 | 26,815 | USD | 90 |
| 2016-10-01 to 2017-03-31 | 52,385 | USD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 391,977 | USD | |
| At 2017-09-30 | 433,531 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 317,494 | USD | |
| At 2017-09-30 | 264,876 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | 2,013,845 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 3,596,218 | USD | 182 |
| 2017-01-01 to 2017-03-31 | 2,204,123 | USD | 90 |
| 2016-10-01 to 2017-03-31 | 3,580,053 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | 1,014,457 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 1,595,319 | USD | 182 |
| 2017-01-01 to 2017-03-31 | 709,919 | USD | 90 |
| 2016-10-01 to 2017-03-31 | 1,059,206 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 154,052,013 | shares | |
| At 2017-09-30 | 138,182,075 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 22,505 | USD | |
| At 2017-09-30 | 12,611 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-03-31 | 3,500 | USD | |
| At 2017-09-30 | 3,500 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | 999,388 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 2,000,899 | USD | 182 |
| 2017-01-01 to 2017-03-31 | 1,494,204 | USD | 90 |
| 2016-10-01 to 2017-03-31 | 2,520,847 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-03-31 | 1,130 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 1,854 | USD | 182 |
| 2017-01-01 to 2017-03-31 | 357 | USD | 90 |
| 2016-10-01 to 2017-03-31 | 477 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | 52,618 | USD | 182 |
| 2016-10-01 to 2017-03-31 | -247,825 | USD | 182 |
Inspect the source
- Entity
- ARCH THERAPEUTICS, INC. / CIK 0001537561
- Captured
- SEC response SHA-256
63d0e84748ee59ab7c6817be68d0a32b23d83273213bc50081bb86253a1d4cc2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001537561.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))